London, England, United Kingdom Arthurian Life Sciences appeared to be the VC, which was created in 2012. The venture was found in Europe in United Kingdom. The main department of described VC is located in the London.
Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight CeQur, Sphere Medical Holding, MedaPhor. The fund has specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as EdTech, Therapeutics. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom.
Considering the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2015. The top amount of exits for fund were in 2005. This Arthurian Life Sciences works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The overall number of key employees were 1.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Arthurian Life Sciences, startups are often financed by Oxford Capital Partners, Fusion IP, Development Bank of Wales. The meaningful sponsors for the fund in investment in the same round are Wyvern Seed Fund, Woodford Investment Management, Vivo Capital. In the next rounds fund is usually obtained by Woodford Investment Management, Shawbrook Bank, Innovate UK.
| Fund Name | Location |
| Axel Johnson | New York, New York, United States |
| Betafabrik | Germany, Köln, Nordrhein-Westfalen |
| Binhai Capital | China, Guangdong, Tianjin |
| Blackstone Alternative Asset Management | New York, New York, United States |
| Centre for Commercialization of Cancer Immunotherapy | Canada, Montréal, Quebec |
| Chengdu Zhengjian | Chengdu, China, Sichuan |
| Daishin Securities | Seoul, Seoul-t'ukpyolsi, South Korea |
| Daxinli Touzi | Beijing, Beijing, China |
| Maine Venture Fund | Maine, Newport, United States |
| Mechanics Bank | California, Richmond, United States |
| Natural Sciences and Engineering Research Council of Canada (NSERC) | - |
| Nextlaw Ventures | California, Palo Alto, United States |
| Osbon Capital Management | Boston, Massachusetts, United States |
| Polymath Ventures | Buenaventura, Colombia, Valle del Cauca |
| Ruiqi Investment | China, Hong Kong, Hong Kong Island |
| Summit Action | New York, New York, United States |
| Traversant | Arizona, Phoenix, United States |
| Ujama | California, Cupertino, United States |
| VinaCapital Ventures | Chicago, Illinois, United States |
| Xterra Inc | California, San Francisco, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Rutherford Health | 01 Jan 2016 | Cardiff, United Kingdom | |||
Apitope | $14M | 29 Sep 2015 | United Kingdom, England | ||
CeQur | $100M | 01 Sep 2015 | Lucerne, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Rutherford Health | 01 Jan 2016 | Cardiff, United Kingdom | |||
Apitope | $14M | 29 Sep 2015 | United Kingdom, England | ||
CeQur | $100M | 01 Sep 2015 | Lucerne, Switzerland |
